Leadership Overview
Piramal Pharma Solutions has 4 executives leading key functions including strategy, operational oversight, manufacturing excellence, and technological innovation.
Committed to advancing global healthcare, Piramal Pharma Solutions delivers comprehensive drug development and manufacturing services while maintaining a steadfast focus on quality, innovation, and patient-centric outcomes across the entire pharmaceutical life cycle.
Committed to advancing global healthcare, Piramal Pharma Solutions delivers comprehensive drug development and manufacturing services while maintaining a steadfast focus on quality, innovation, and patient-centric outcomes across the entire pharmaceutical life cycle.
Leadership Roles at Piramal Pharma Solutions
Bhargava Chari - Chief Executive Officer
Bhargava Chari, the Chief Executive Officer at Piramal Pharma Solutions, directs the overarching corporate strategy and global business expansion. Chari architects the long-term vision for the organization, ensuring alignment across the integrated network of facilities spanning North America, Europe, and Asia. By prioritizing the development of highly potent APIs and complex drug delivery systems, the Chief Executive Officer drives the company toward market leadership in the CDMO sector. This leadership role involves constant engagement with the Board to optimize capital allocation and resource distribution. Bhargava Chari maintains a focus on scaling the biologics and gene therapy portfolios to meet evolving innovator requirements. Through rigorous oversight of global operations, the Chief Executive Officer secures the competitive positioning of the firm. Ultimately, Chari fosters a culture of excellence that supports the delivery of end-to-end pharmaceutical solutions for clients worldwide.
Sourabh Lodhi - Co-Chief Executive Officer
Sourabh Lodhi, the Co-Chief Executive Officer at Piramal Pharma Solutions, manages the strategic integration of specialized service lines and commercial partnerships. Lodhi oversees the expansion of antibody-drug conjugation capabilities and peptide product development, ensuring these high-growth areas receive necessary investment. The Co-Chief Executive Officer coordinates with regional leaders to streamline the supply chain for finished dosage forms across international markets. By focusing on the commercial supply of APIs, the Co-Chief Executive Officer strengthens the value proposition for generic and innovator companies. Sourabh Lodhi drives operational synergy between the various manufacturing sites to maximize efficiency and output quality. This role requires deep collaboration with the executive team to refine the service model for clinical trial supplies. Through proactive market analysis, Lodhi identifies emerging opportunities in the biologics space, ensuring the organization remains at the forefront of pharmaceutical manufacturing technology.
Herve Berdou - Chief Operating Officer
Herve Berdou, the Chief Operating Officer at Piramal Pharma Solutions, executes the daily manufacturing operations and facility management across the global network. Berdou optimizes the production workflows for sterile fill/finish and potent solid oral drug products to ensure strict adherence to regulatory standards. The Chief Operating Officer monitors the performance metrics of all manufacturing sites, driving continuous improvement in process development services. By managing the technical infrastructure, the Chief Operating Officer ensures that the organization meets the complex demands of modern drug life cycles. Herve Berdou coordinates with site leads to maintain operational consistency across North American, European, and Asian facilities. This leadership role involves implementing advanced manufacturing technologies to enhance throughput and quality control. Through meticulous oversight of production capacity, Berdou supports the company's commitment to reliable, high-quality service delivery for all pharmaceutical partners.
Rubina Malik - Chief Technology Officer
Rubina Malik, the Chief Technology Officer at Piramal Pharma Solutions, leads the research and development initiatives focused on cutting-edge pharmaceutical technologies. Malik architects the technical roadmap for biologics, including vaccines and monoclonal antibodies, while integrating the capabilities provided by Yapan Bio Private Limited. The Chief Technology Officer drives innovation in drug discovery solutions, ensuring the organization utilizes the latest scientific advancements to solve complex development challenges. By overseeing the implementation of new analytical tools and manufacturing platforms, the Chief Technology Officer enhances the firm's ability to handle highly potent compounds. Rubina Malik collaborates with the broader leadership team to align technological investments with market needs and client requirements. This role involves fostering a culture of scientific rigor and technical excellence across all R&D departments. Through strategic oversight of the technology portfolio, Malik ensures the company maintains a distinct competitive advantage in the global CDMO landscape.
Explore Leadership Teams in Manufacturing
Cipla Limited is a global pharmaceutical company based in Mumbai, India, with operations in India, the United States, South Africa, and other international markets. Through its Pharmaceuticals and New Ventures segments, the company develops, manufactures, markets, and distributes a broad range of generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and finished formulations. Its products address multiple therapeutic areas, including cardiovascular disease, pulmonary and kidney conditions, neurological and psychiatric disorders, HIV/AIDS, respiratory and asthma care, oncology, diabetes and metabolic disorders, infectious diseases, critical care, women’s health, ophthalmology, and child health. In addition to its core pharmaceutical portfolio, Cipla is active in consumer healthcare, biosimilars, and specialty medicine businesses. Founded in 1935, Cipla has grown into a major global healthcare player.
Company Leadership KI
SS
LB
Bristol-Myers Squibb operates as a global biopharmaceutical organization dedicated to discovering, developing, and manufacturing prescription medications that address serious patient needs across multiple therapeutic domains. The company's scientific expertise spans oncology, cardiovascular disease, immunoscience, and virology, with particular depth in treating complex conditions including HIV and cancer. Through sustained investment in research and development, the organization has built a comprehensive medication portfolio that combines innovative cancer immunotherapies, anticoagulant therapies, and treatments for chronic viral infections. The company's operational footprint extends across major markets worldwide, enabling efficient distribution and patient access to its therapeutic solutions. Bristol-Myers Squibb pursues a collaborative approach to medical innovation, actively engaging in research partnerships and strategic alliances that accelerate the development of new treatment options. This commitment to external collaboration complements the organization's internal capabilities, creating a dynamic environment where scientific breakthroughs can translate into meaningful therapeutic advances. Bristol-Myers Squibb's medication portfolio reflects decades of pharmaceutical expertise and a strategic focus on disease areas where unmet medical needs remain significant.
Company Leadership BK
US
BT
KK
Vertex Pharmaceuticals Incorporated is a biotechnology company that develops and commercializes medicines for serious diseases with significant unmet medical needs. Its portfolio includes therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain. The company also advances research programs in kidney disease, type 1 diabetes, myotonic dystrophy, and other genetic disorders, serving patients through healthcare providers, specialty pharmacies, hospitals, and distributors worldwide.
Company Leadership
AL
JL
ND
Bliss GVS Pharma Limited is a global pharmaceutical company specializing in the manufacturing of a wide range of pharmaceutical products, including capsules, creams, injections, and various healthcare items. The company is recognized as the world's largest manufacturer of suppositories and pessaries, operating world-class facilities that prioritize quality and efficiency. Their mission focuses on discovering and rediscovering pharmaceutics to enhance well-being while increasing the accessibility of pharmaceuticals worldwide. The intended clients include healthcare providers and consumers seeking reliable and effective pharmaceutical solutions.
Company Leadership VD
SJ
AM
DS
Frequently Asked Questions Regarding Piramal Pharma Solutions Top Executives and Leadership Team
